Drawing for HALO

USPTO serial 90298797

HALO

Reviewed by CopyMark Law Group

Status 654
Filing date
Status date
Registration date
—
Examiner
RENNEKER, CHRISTOPHER JOHN
Law office
TMO LAW OFFICE 113

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with HALO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Holiday W. Banta

Holiday W. Banta ICE MILLER LLPONE AMERICAN SQUARE, SUITE 2900INDIANAPOLIS, IN 46282UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
035Business risk management services for medical device, life science, pharmaceutical, biotech, in vitro diagnostic device, and software as a medical device manufacturers in the fields of medical device manufacturing, life sciences medical device manufacturing, pharmaceutical manufacturing, biotech manufacturing, in vitro diagnostic device manufacturing, and software as a medical device manufacturing; business management and consulting services for medical device, life science, pharmaceutical, biotech, in vitro diagnostic device, and software as a medical device manufacturers for the fields of medical device manufacturing, life sciences medical device manufacturing, pharmaceutical manufacturing, biotech manufacturing, in vitro diagnostic device manufacturing, and software as a medical device manufacturing, namely, providing industry expertise and supplier management; records management services for medical device, life science, pharmaceutical, biotech, in vitro diagnostic device, and software as a medical device manufacturers, namely, document indexing for others in the fields of medical device manufacturing, life sciences medical device manufacturing, pharmaceutical manufacturing, biotech manufacturing, in vitro diagnostic device manufacturing, and software as a medical device manufacturing; regulatory information management services for medical device, life science, pharmaceutical, biotech, in vitro diagnostic device, and software as a medical device manufacturers in the fields of medical device manufacturing, life sciences medical device manufacturing, pharmaceutical manufacturing, biotech manufacturing, in vitro diagnostic device manufacturing, and software as a medical device manufacturingACTIVE—
042Quality management services, namely, quality evaluation and analysis, quality assurance, quality control, design control, quality and safety audit management, quality and safety product and system change management, quality and safety complaint management, quality and safety nonconformance management, quality and safety training management, and quality and safety corrective action and preventive action management, in the fields of medical device manufacturing, life sciences medical device manufacturing, pharmaceutical manufacturing, biotech manufacturing, in vitro diagnostic device manufacturing, and software as a medical device manufacturing; Software as a service (SAAS) services featuring software using artificial intelligence for use in software development and machine learning in the fields of medical device manufacturing, life sciences medical device manufacturing, pharmaceutical manufacturing, biotech manufacturing, in vitro diagnostic device manufacturing, and software as a medical device manufacturingACTIVE—
045Consulting services in the field of state and federal regulatory compliance requirements for medical device manufacturing, life sciences medical device manufacturing, pharmaceutical manufacturing, biotech manufacturing, in vitro diagnostic device manufacturing, and software as a medical device manufacturing; Tracking and monitoring regulatory requirements in the fields of medical device manufacturing, life sciences medical device manufacturing, pharmaceutical manufacturing, biotech manufacturing, in vitro diagnostic device manufacturing, and software as a medical device manufacturing for regulatory compliance purposesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 11, 2026RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
May 14, 2026RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Oct 17, 2025RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Apr 16, 2025GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Apr 16, 2025GNSLLETTER OF SUSPENSION E-MAILED—
Apr 16, 2025CNSLSUSPENSION LETTER WRITTEN—
Apr 16, 2025RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Oct 15, 2024RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Apr 17, 2024RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Oct 17, 2023RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Apr 19, 2023RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Oct 20, 2022RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Apr 20, 2022RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Oct 18, 2021GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Oct 18, 2021GNSLLETTER OF SUSPENSION E-MAILED—
Oct 18, 2021CNSLSUSPENSION LETTER WRITTEN—
Oct 5, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 4, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 4, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 9, 2021GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 9, 2021GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 9, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 9, 2021DOCKASSIGNED TO EXAMINER—
Jan 4, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 7, 2020NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance